INS and Hyperglycemia: To confirm the in vivo BLI finding that luciferase expression under the insulin promoter was elevated in the liver under hyperglycemia, liver autopsy samples were obtained on day 8 and luciferase assays were performed on tissue lysates from the liver to quantify the luciferase expression in control and treated mice.